Published in Cancer Res Treat on January 13, 2015
A minimalist policy for breast cancer surveillance. JAMA (1991) 3.08
Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials. J Clin Oncol (2001) 2.28
The contribution of routine follow-up mammography to an early detection of asynchronous contralateral breast cancer. Cancer (1991) 2.10
Follow-up strategies for women treated for early breast cancer. Cochrane Database Syst Rev (2005) 1.98
Evaluation of an intensive strategy for follow-up and surveillance of primary breast cancer. Ann Surg Oncol (1998) 1.64
Popularity of less frequent follow up for breast cancer in randomised study: initial findings from the hotline study. BMJ (1997) 1.54
Local recurrence after breast-conserving therapy for invasive breast cancer: high incidence in young patients and association with poor survival. Int J Radiat Oncol Biol Phys (1998) 1.49
Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysis. Breast Cancer Res Treat (2008) 1.30
Effectiveness of routine visits and routine tests in detecting isolated locoregional recurrences after treatment for early-stage invasive breast cancer: a meta-analysis and systematic review. J Clin Oncol (2004) 1.27
Periodic follow-up after breast cancer and the effect on survival. Eur J Surg (2001) 0.95
Outpatient follow-up after treatment for early breast cancer: updated results after 5 years. Clin Oncol (R Coll Radiol) (2001) 0.93
Routine follow-up examinations in breast cancer patients have minimal impact on life expectancy: a simulation study. Ann Oncol (2001) 0.92
Follow-up cost of breast cancer patients with localized disease after primary treatment: a randomized trial. Breast Cancer Res Treat (2005) 0.88
Results of breast conserving therapy for early breast cancer and the role of mammographic follow-up. Int J Radiat Oncol Biol Phys (1997) 0.86
A nationwide survey of knowledge of and compliance with cancer pain management guidelines by korean physicians. Cancer Res Treat (2014) 1.51
The Basic Facts of Korean Breast Cancer in 2012: Results from a Nationwide Survey and Breast Cancer Registry Database. J Breast Cancer (2015) 0.94
Lymph Node Ratio as a Risk Factor for Locoregional Recurrence in Breast Cancer Patients with 10 or More Axillary Nodes. J Breast Cancer (2016) 0.85
Current practices in cancer pain management in Asia: a survey of patients and physicians across 10 countries. Cancer Med (2015) 0.81
Hepatitis B reactivation in multiple myeloma patients with resolved hepatitis B undergoing chemotherapy. Liver Int (2015) 0.79
Association between Mutation and Expression of TP53 as a Potential Prognostic Marker of Triple-Negative Breast Cancer. Cancer Res Treat (2016) 0.79
Mutational profiling of brain metastasis from breast cancer: matched pair analysis of targeted sequencing between brain metastasis and primary breast cancer. Oncotarget (2015) 0.79
Prognostic factors for survivals from first relapse in breast cancer patients: analysis of deceased patients. Radiat Oncol J (2013) 0.79
The clinical impact of 21-gene recurrence score on treatment decisions for patients with hormone receptor-positive early breast cancer in Korea. Cancer Res Treat (2014) 0.78
Genetic anticipation of familial breast cancer with or without BRCA mutation in the Korean population. Cancer Genet (2014) 0.78
Basic Facts of Breast Cancer in Korea in 2014: The 10-Year Overall Survival Progress. J Breast Cancer (2017) 0.78
Limited Supraclavicular Radiation Field in Breast Cancer With ≥ 10 Positive Axillary Lymph Nodes. Clin Breast Cancer (2015) 0.77
Invited Commentary on: Can CD44+/CD24- Tumor Stem Cells Be Used to Determine the Extent of Breast Cancer Invasion Following Neoadjuvant Chemotherapy? J Breast Cancer (2011) 0.76
Clinicopathological Features and Prognostic Factors Affecting Survival Outcomes in Isolated Locoregional Recurrence of Breast Cancer: Single-Institutional Series. PLoS One (2016) 0.76
Anticancer effect of silibinin on the xenograft model using MDA-MB-468 breast cancer cells. Ann Surg Treat Res (2014) 0.76
Frequency of MED12 mutations in phyllodes tumors: Inverse correlation with histologic grade. Genes Chromosomes Cancer (2016) 0.76
Micropapillary mucinous adenocarcinoma of the lung: a brief case report. Korean J Pathol (2013) 0.75
Proportion and clinical outcomes of postoperative radiotherapy omission after breast-conserving surgery in women with breast cancer. J Breast Cancer (2015) 0.75
Clinicopathologic Features and Long-Term Outcomes of Elderly Breast Cancer Patients: Experiences at a Single Institution in Korea. Cancer Res Treat (2016) 0.75
Analysis of BRIP1 Variants among Korean Patients with BRCA1/2 Mutation-Negative High-Risk Breast Cancer. Cancer Res Treat (2016) 0.75
Commentary on: Incidental Breast Cancers Identified in a One-Stop Symptomatic Breast Clinic. J Breast Cancer (2011) 0.75
The Impacts of Inclusion in Clinical Trials on Outcomes among Patients with Metastatic Breast Cancer (MBC). PLoS One (2016) 0.75
Retracted Clinical significance of the axillary arch in sentinel lymph node biopsy. J Breast Cancer (2014) 0.75
Radiologic Findings of Primary Mucinous Cystadenocarcinoma of the Breast: A Report of Two Cases and a Literature Review. J Breast Cancer (2016) 0.75
Evaluation of Pathologic Complete Response in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: Experience in a Single Institution over a 10-Year Period. J Pathol Transl Med (2016) 0.75
Comparison of Clinicopathological Features and Treatment Results between Invasive Lobular Carcinoma and Ductal Carcinoma of the Breast. J Breast Cancer (2015) 0.75
Assessment of pathologic response and long-term outcome in locally advanced breast cancers after neoadjuvant chemotherapy: comparison of pathologic classification systems. Breast Cancer Res Treat (2016) 0.75
Effects of exercise intervention in breast cancer patients: is mobile health (mHealth) with pedometer more effective than conventional program using brochure? Breast Cancer Res Treat (2016) 0.75
Inadequate treatment practices for pain relief and adverse event management in cancer patients across 10 countries/regions in Asia: a call for greater efforts to improve standards for patient care. Asia Pac J Clin Oncol (2017) 0.75
Patient-reported assessment of self-management strategies of health in cancer patients: development and validation of the Smart Management Strategy for Health Assessment Tool (SAT). Psychooncology (2015) 0.75
Clinical Outcomes and Prognostic Factors of Pathologic N3 Breast Cancer Treated With Modern Standard Treatments. Clin Breast Cancer (2015) 0.75
Prognostic Modeling in Pathologic N1 Breast Cancer Without Elective Nodal Irradiation After Current Standard Systemic Management. Clin Breast Cancer (2015) 0.75